Versor Investments LP Acquires New Holdings in Zoetis Inc. $ZTS

Versor Investments LP acquired a new stake in Zoetis Inc. (NYSE:ZTS) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 3,436 shares of the company’s stock, valued at approximately $536,000.

Several other large investors have also recently modified their holdings of the business. Nova Wealth Management Inc. bought a new position in Zoetis during the 1st quarter worth $25,000. 1248 Management LLC bought a new position in Zoetis during the 1st quarter worth $27,000. Saudi Central Bank bought a new position in shares of Zoetis during the first quarter worth about $29,000. REAP Financial Group LLC raised its position in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after acquiring an additional 131 shares during the last quarter. Finally, Cornerstone Planning Group LLC raised its position in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after acquiring an additional 88 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ZTS. Leerink Partnrs downgraded Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Piper Sandler raised their price target on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Argus reissued a “buy” rating and set a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. Stifel Nicolaus set a $140.00 target price on shares of Zoetis in a research note on Tuesday. Finally, UBS Group lowered their price objective on Zoetis from $165.00 to $158.00 and set a “neutral” rating for the company in a research report on Monday, October 20th. Four investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $192.14.

Zoetis Trading Down 13.6%

ZTS opened at $124.70 on Wednesday. Zoetis Inc. has a 1-year low of $122.00 and a 1-year high of $181.85. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The company has a market cap of $55.27 billion, a P/E ratio of 21.46, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a fifty day moving average price of $146.33 and a two-hundred day moving average price of $153.24.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the previous year, the firm posted $1.58 earnings per share. The business’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.6%. Zoetis’s payout ratio is currently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.